Coated and Hollow Microneedle-Mediated Intradermal Immunization in Mice with Diphtheria Toxoid Loaded Mesoporous Silica Nanoparticles
暂无分享,去创建一个
Koen van der Maaden | Gideon Kersten | Alexander Kros | Wim Jiskoot | Guangsheng Du | Laura Woythe | W. Jiskoot | J. Bouwstra | A. Kros | G. Kersten | Stefan Romeijn | Joke A Bouwstra | M. Leone | S. Romeijn | K. van der Maaden | G. Du | Mara Leone | Laura Woythe
[1] V. Mourya,et al. Trimethyl chitosan and its applications in drug delivery , 2009, Journal of materials science. Materials in medicine.
[2] W. Jiskoot,et al. Impact-Insertion Applicator Improves Reliability of Skin Penetration by Solid Microneedle Arrays , 2014, The AAPS Journal.
[3] J. Moon,et al. Nanoparticle Drug Delivery Systems Designed to Improve Cancer Vaccines and Immunotherapy , 2015, Vaccines.
[4] W. Jiskoot,et al. Microneedle-Based Transcutaneous Immunisation in Mice with N-Trimethyl Chitosan Adjuvanted Diphtheria Toxoid Formulations , 2010, Pharmaceutical Research.
[5] D. Irvine,et al. Particulate vaccines: on the quest for optimal delivery and immune response. , 2011, Drug discovery today.
[6] N. Mitter,et al. Silica vesicles as nanocarriers and adjuvants for generating both antibody and T-cell mediated immune resposes to Bovine Viral Diarrhoea Virus E2 protein. , 2014, Biomaterials.
[7] Koen van der Maaden,et al. Layer-by-Layer Assembly of Inactivated Poliovirus and N-Trimethyl Chitosan on pH-Sensitive Microneedles for Dermal Vaccination. , 2015, Langmuir : the ACS journal of surfaces and colloids.
[8] N. Mitter,et al. Mesoporous silica nanoparticles as antigen carriers and adjuvants for vaccine delivery. , 2013, Nanoscale.
[9] I. Toth,et al. Modern Subunit Vaccines: Development, Components, and Research Opportunities , 2013, ChemMedChem.
[10] Koen van der Maaden,et al. Hollow microneedle‐mediated micro‐injections of a liposomal HPV E743–63 synthetic long peptide vaccine for efficient induction of cytotoxic and T‐helper responses , 2018, Journal of controlled release : official journal of the Controlled Release Society.
[11] N. Mitter,et al. Mesoporous silica nanoparticles act as a self-adjuvant for ovalbumin model antigen in mice. , 2013, Small.
[12] W. Jiskoot,et al. Immune Modulation by Adjuvants Combined with Diphtheria Toxoid Administered Topically in BALB/c Mice After Microneedle Array Pretreatment , 2009, Pharmaceutical Research.
[13] W. Saltzman,et al. Controlled release for local delivery of drugs: barriers and models. , 2014, Journal of controlled release : official journal of the Controlled Release Society.
[14] A. Boyle,et al. Mesoporous Silica Nanoparticles with Large Pores for the Encapsulation and Release of Proteins. , 2016, ACS applied materials & interfaces.
[15] S. Nakagawa,et al. Transcutaneous vaccines: novel advances in technology and delivery for overcoming the barriers. , 2011, Vaccine.
[16] W. Jiskoot,et al. Ovalbumin-coated pH-sensitive microneedle arrays effectively induce ovalbumin-specific antibody and T-cell responses in mice. , 2014, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[17] J. Bouwstra,et al. Dissolving Microneedle Patches for Dermal Vaccination , 2017, Pharmaceutical Research.
[18] B. Greenwood. The contribution of vaccination to global health: past, present and future , 2014, Philosophical Transactions of the Royal Society B: Biological Sciences.
[19] C. Oomens,et al. Diphtheria toxoid and N-trimethyl chitosan layer-by-layer coated pH-sensitive microneedles induce potent immune responses upon dermal vaccination in mice. , 2017, Journal of controlled release : official journal of the Controlled Release Society.
[20] T. Grimmond,et al. Exposure Survey of Trends in Occupational Practice (EXPO‐S.T.O.P.) 2015: A national survey of sharps injuries and mucocutaneous blood exposures among health care workers in US hospitals , 2017, American journal of infection control.
[21] Koen van der Maaden,et al. Microneedle technologies for (trans)dermal drug and vaccine delivery. , 2012, Journal of controlled release : official journal of the Controlled Release Society.
[22] Jung-Hwan Park,et al. Microneedles for drug and vaccine delivery. , 2012, Advanced drug delivery reviews.
[23] D. Irvine,et al. Releasable layer-by-layer assembly of stabilized lipid nanocapsules on microneedles for enhanced transcutaneous vaccine delivery. , 2012, ACS nano.
[24] Thomas Hankemeier,et al. Novel Hollow Microneedle Technology for Depth-Controlled Microinjection-Mediated Dermal Vaccination: A Study with Polio Vaccine in Rats , 2014, Pharmaceutical Research.
[25] W. Hennink,et al. Diphtheria toxoid-containing microparticulate powder formulations for pulmonary vaccination: preparation, characterization and evaluation in guinea pigs. , 2007, Vaccine.
[26] I. Toth,et al. Modern Subunit Vaccines: Development, Components, and Research Opportunities , 2013 .
[27] Chun-Xia Zhao,et al. Nanoparticle vaccines. , 2014, Vaccine.
[28] Abraham J. Koster,et al. Intradermal vaccination with hollow microneedles: A comparative study of various protein antigen and adjuvant encapsulated nanoparticles , 2017, Journal of controlled release : official journal of the Controlled Release Society.
[29] J. Leask,et al. Vaccine decision-making begins in pregnancy: Correlation between vaccine concerns, intentions and maternal vaccination with subsequent childhood vaccine uptake. , 2017, Vaccine.
[30] Nanolayered chemical modification of silicon surfaces with ionizable surface groups for pH-triggered protein adsorption and release: application to microneedles. , 2013, Journal of materials chemistry. B.
[31] C. Russell Middaugh,et al. Nanotechnology in vaccine delivery☆ , 2008, Advanced Drug Delivery Reviews.
[32] R. Bronaugh,et al. Methods for in vitro percutaneous absorption studies. II. Animal models for human skin. , 1982, Toxicology and applied pharmacology.
[33] W. Jiskoot,et al. Orchestrating immune responses: How size, shape and rigidity affect the immunogenicity of particulate vaccines. , 2016, Journal of controlled release : official journal of the Controlled Release Society.
[34] W. Jiskoot,et al. Adjuvant effect of cationic liposomes and CpG depends on administration route. , 2011, Journal of controlled release : official journal of the Controlled Release Society.
[35] Elly van Riet,et al. Efficient induction of immune responses through intradermal vaccination with N-trimethyl chitosan containing antigen formulations. , 2010, Journal of controlled release : official journal of the Controlled Release Society.
[36] Ryan F. Donnelly,et al. Microneedles: A New Frontier in Nanomedicine Delivery , 2016, Pharmaceutical Research.
[37] M. Prausnitz,et al. Transdermal Influenza Immunization with Vaccine-Coated Microneedle Arrays , 2009, PLoS ONE.
[38] S. Reed,et al. Key roles of adjuvants in modern vaccines , 2013, Nature Medicine.
[39] Koen van der Maaden,et al. Mesoporous Silica Nanoparticle-Coated Microneedle Arrays for Intradermal Antigen Delivery , 2017, Pharmaceutical Research.